IVERMECTIN & FENBENDAZOLE: HOW THEY WORK TOGETHER
Ivermectin and Fenbendazole are both anti-parasitic drugs (anthelmintics), but they act through different mechanisms and target different areas of the body. When used strategically—whether in rotation or combination—they may offer broad-spectrum support against parasites and other chronic conditions.
Ivermectin
Mechanism: Binds to glutamate-gated chloride channels in parasite nerve and muscle cells, causing paralysis and death.
Targets: Blood parasites, filarial worms, lice, mites, and some gastrointestinal worms.
Strengths: Deep tissue penetration—including the brain, lungs, and skin.
Best for: Systemic infections affecting the nervous system, lungs, blood, and skin.
Fenbendazole
Mechanism: Disrupts microtubule formation by binding to beta-tubulin, preventing parasite cells from absorbing nutrients and reproducing.
Targets: Primarily gastrointestinal parasites (roundworms, hookworms, whipworms, some tapeworms).
Strengths: Works locally in the digestive tract and affects parasite metabolism.
Best for: Intestinal parasitic infections.
Why Use Them Together?
BenefitExplanationBroader coverageTargets more parasite types across more tissues.Reduced resistanceDifferent mechanisms lower the chance of parasites adapting.Tissue synergyIvermectin reaches deep tissues; Fenbendazole works in digestive and detox organs.Biofilm disruptionFenbendazole may weaken defenses, allowing Ivermectin to act more effectively.
Protocol Tips (Always Under Medical Guidance)
• Cycle: Often used in 3–5 day on/off cycles or rotated weekly.
• Binders: Some people use activated charcoal or bentonite clay to support detoxification.
• Detox support: Support liver and kidney function as advised by a healthcare professional.
• Hydration: Stay well hydrated and replenish electrolytes.
Join my telegram channel and comment "Protocol" to get the full protocol Leaflet. https://t.co/FrJ4YkzsL1
NEW STUDY: Topical vitamin C in DMSO completely ELIMINATED 56% of biopsy-confirmed skin cancers in just 12 weeks.
44% of the squamous cell carcinoma lesions SHRANK by over 85%.
94% of patients were able to AVOID surgery.
The average cancer lesion size dropped 71%.
The treatment was 30% ascorbic acid in a 95% DMSO/5% distilled-water solution, applied twice daily for 12 weeks.
DMSO was used as a skin-penetration enhancer, helping the vitamin C pass through the outer skin barrier and reach the lesion more effectively.
Did you know there is a published U.S. patent application titled “Cure for Cancer” involving salicylic acid?
Large containers are at Tractor Supply. Patent application US20040248858A1 claimed that salicylic acid could be applied directly to cancerous tissue to reduce or remove cancer—including leukemia. The application was published in 2004 but later abandoned, so it was never an approved patent or proven cancer treatment.
A patent application is not clinical proof—but the document is real. Read it for yourself and ask why salicylic acid and related compounds continue to be studied in cancer research.
Visit https://t.co/OGSQ9ntqrK, join my email list, and select Subscribe in the menu for more information.
#SalicylicAcid #CancerResearch #MedicalPatents #AspirinResearch #tractorsupply